Lawful routes
Psychedelic and ketamine clinical trials recruiting now
202 trials registered on ClinicalTrials.gov were recruiting on 13 Nov 2026, 118 of them with sites in the United States. By substance: Psilocybin 102, Ketamine / esketamine 72, MDMA 22, DMT / ayahuasca 12, LSD 5, 5-MeO-DMT 1.
Psilocybin, DMT and ibogaine are Schedule I under federal law, so outside Oregon's and Colorado's licensed psilocybin programmes a registered trial is one of the few lawful ways to receive them in the US. (Legal Information Institute (Cornell) reproducing the U.S. Code, current)
From the ClinicalTrials.gov registry (US National Library of Medicine), read through its public API on 13 Nov 2026: studies marked as recruiting whose interventions name the substance. Titles, sponsors, phases, conditions and sites are the registry's own entries, written by the sponsors. We have not vetted any trial, and recruiting status changes; the registry record and the study team have the current eligibility rules.
By condition
- Depression85 trials, 48 in the US
- PTSD29 trials, 21 in the US
- Alcohol use disorder12 trials, 5 in the US
- Opioid use disorder13 trials, 10 in the US
- Cocaine and methamphetamine3 trials, 2 in the US
- Anxiety13 trials, 9 in the US
- Cancer and end-of-life distress13 trials, 7 in the US
- Eating disorders3 trials, 2 in the US
- OCD8 trials, 6 in the US
- Bipolar disorder5 trials, 3 in the US
Too few for their own page (under 3): smoking and nicotine (2), gambling (1). They are listed on the condition and state pages they belong to.
By US state
- Maryland22
- California20
- New York17
- Connecticut16
- Texas12
- Georgia8
- Massachusetts8
- Ohio5
- Alabama4
- Colorado4
- Pennsylvania4
- Tennessee4
- Utah4
- Washington4
- Florida3
- Illinois3
- Iowa3
- Minnesota3
- New Mexico3
- Rhode Island3
- Wisconsin3
States with at least 3 recruiting trials at an open site. Trials in other states are on the condition pages.
How taking part works
- ClinicalTrials.gov, run by the US National Library of Medicine, lists studies using information supplied by each study's sponsor or investigator. Listing a study does not mean it has been evaluated by the US federal government, and the NLM advises talking to your health care provider about the risks and potential benefits before taking part. (U.S. National Library of Medicine (NIH), Oct 2023)
- The National Institute on Aging's list of questions to ask before joining a trial includes whether it will cost anything to take part, whether expenses such as travel, parking, lodging or meals are reimbursed, and whether your insurance will pay for costs the research does not cover. Ask the study team; the answer varies by study. (National Institute on Aging (NIH), current page)